Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
A 1:1 ratio is scientifically optimal. No clinically validated ratio was identified
Built for responsible research workflows with clear documentation, batch visibility, and a clean catalog experience
Researched combination of BPC-157 (10mg), TB-500 (10mg), and GHK-Cu (50mg) for VEGFR2 signalling, actin dynamics, and extracellular matrix studies Select Option Each unit contains 10 mg BPC-157, 10 mg TB-500, and 50 mg GHK-Cu (total 70 mg)
"Pre-Ugaritic Documentation of Baal"
Both are for laboratory research only
Any use outside of formally approved clinical trials falls outside the regulatory framework that governs medicines safety in the UK, meaning that individuals who obtain and use retatrutide independently do so without the quality assurance, standardised dosing oversight, and pharmacovigilance protections afforded by licensed medicines
US$ 25.24
US$ 23.37
US$ 25.35
US$ 24.89
